Literature DB >> 16246958

Type 5 phosphodiesterase inhibition: the focus shifts to the heart.

Marc J Semigran.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 16246958     DOI: 10.1161/CIRCULATIONAHA.105.577627

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  3 in total

Review 1.  The emerging role for type 5 phosphodiesterase inhibition in heart failure.

Authors:  Gregory D Lewis; Marc J Semigran
Journal:  Curr Heart Fail Rep       Date:  2006-09

2.  Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes.

Authors:  Liliana R V Castro; Ignacio Verde; Dermot M F Cooper; Rodolphe Fischmeister
Journal:  Circulation       Date:  2006-05-01       Impact factor: 29.690

Review 3.  Right ventricular failure complicating heart failure: pathophysiology, significance, and management strategies.

Authors:  Mobusher Mahmud; Hunter C Champion
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.